Cargando…

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Picod, Adrien, Rebibou, Jean-Michel, Dossier, Antoine, Cador, Bérengère, Ribes, David, Vasco-Moynet, Claire, Stephan, Caroline, Bellal, Mathieu, Wynckel, Alain, Poullin, Pascale, Péju, Edwige, Ricard, Laure, Kahn, Jean-Emmanuel, Bouzid, Raïda, Benhamou, Ygal, Joly, Bérangère, Veyradier, Agnès, Coppo, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Letter to Blood
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916825/ https://www.ncbi.nlm.nih.gov/pubmed/35271696 http://dx.doi.org/10.1182/blood.2021015149

Ejemplares similares

More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura
por: Picod, Adrien, et al.
Publicado: (2022)

The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review
por: Joseph, Adrien, et al.
Publicado: (2023)

Preemptive cyclosporin A in immune‐mediated thrombotic thrombocytopenic purpura
por: Comparon, Celine, et al.
Publicado: (2022)

ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology
por: Joly, Bérangère S., et al.
Publicado: (2022)

Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura
por: Pereira, Leydi C. Velasquez, et al.
Publicado: (2020)

Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
por: Beranger, Nicolas, et al.
Publicado: (2020)

Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpura
por: Stubbs, Matthew J., et al.
Publicado: (2021)

Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay
por: Bonnez, Quintijn, et al.
Publicado: (2023)

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura
por: Roriz, Mélanie, et al.
Publicado: (2015)

HLA-DRB1*11 is a strong risk factor for acquired thrombotic thrombocytopenic purpura in children
por: Joly, Bérangère S., et al.
Publicado: (2020)

SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura
por: Shah, Hridaya, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors
por: Martino, Suella, et al.
Publicado: (2016)

Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
por: Schelpe, An-Sofie, et al.
Publicado: (2019)

Refractory Auto-Immune Thrombotic Thrombocytopenic Pupura Successfully Treated With Caplacizumab
por: Mellaza, Chloé, et al.
Publicado: (2020)

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)
por: Paulsen, Finn-Ole, et al.
Publicado: (2021)

Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure
por: Joseph, Adrien, et al.
Publicado: (2022)

Predictive Scores for Early Identification of Immune-Mediated Thrombotic Thrombocytopenic Purpura: Room for Improvement?
por: Joseph, Adrien, et al.
Publicado: (2022)

TTP: From empiricism for an enigmatic disease to targeted molecular therapies
por: Graça, Nuno A. G., et al.
Publicado: (2022)

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19
por: Joly, Bérangère S., et al.
Publicado: (2020)

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
por: Travert, Benoît, et al.
Publicado: (2021)

Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease
por: Delmas, Yahsou, et al.
Publicado: (2015)

Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity
por: Tellier, Edwige, et al.
Publicado: (2022)

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2018)

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2021)

Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP
por: De Waele, Laure, et al.
Publicado: (2021)

Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report
por: Mousseaux, Cyril, et al.
Publicado: (2020)

Curious beads for a clinical pearl
por: Decker, Julien, et al.
Publicado: (2014)

Intracranial haemorrhage in thrombocytopenic haematology patients—a nested case–control study: the InCiTe study protocol
por: Estcourt, Lise J, et al.
Publicado: (2014)

Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura
por: Graça, Nuno A. G., et al.
Publicado: (2019)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients
por: Oliva-Ariza, Guillermo, et al.
Publicado: (2023)

Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
por: Sow, Cissé, et al.
Publicado: (2022)

Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2022)

COVID-19 as a potential trigger of complement-mediated atypical HUS
por: El Sissy, Carine, et al.
Publicado: (2021)

Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
por: Coppo, Paul, et al.
Publicado: (2010)

Performance characteristics of a novel blood bag in-line closure device and subsequent product quality assessment
por: Serrano, Katherine, et al.
Publicado: (2010)

Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors
por: Wong, Horas Tze Hoo, et al.
Publicado: (2015)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Estimation of the number of blood donors during the COVID‐19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission
por: Yuan, Zhaohu, et al.
Publicado: (2020)

Deferral rate variability in blood donor eligibility assessment
por: de Kort, Wim, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_937f3ie0bthuhivnrkcf58ado6